Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $161.59 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $76.38 | 1 | $0 (2018) |
| Edwards Lifesciences Corporation | $39.86 | 1 | $0 (2024) |
| AbbVie Inc. | $23.79 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.56 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.86 | 1 | Edwards Lifesciences Corporation ($39.86) |
| 2023 | $23.79 | 1 | AbbVie Inc. ($23.79) |
| 2018 | $97.94 | 2 | Novo Nordisk Inc ($76.38) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $39.86 | General |
| Category: Transcatheter Heart Valves | ||||||
| 02/22/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $76.38 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,173 | 1,967 | $304,847 | $125,101 |
| 2022 | 27 | 1,152 | 1,871 | $316,585 | $114,800 |
| 2021 | 21 | 1,031 | 1,631 | $251,442 | $89,948 |
| 2020 | 23 | 978 | 1,547 | $202,640 | $66,323 |
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 121 | 288 | $82,656 | $40,556 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 262 | $51,876 | $25,992 | 50.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 91 | 91 | $22,750 | $12,046 | 52.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 102 | $14,586 | $6,746 | 46.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $4,250 | $4,165 | 98.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 38 | 66 | $8,844 | $3,758 | 42.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 31 | 46 | $9,108 | $3,699 | 40.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 34 | $10,846 | $3,381 | 31.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 140 | 362 | $7,964 | $3,041 | 38.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 37 | 37 | $3,145 | $2,788 | 88.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 19 | $9,405 | $2,663 | 28.3% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 19 | 22 | $29,040 | $2,050 | 7.1% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 37 | 61 | $5,978 | $1,892 | 31.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 54 | $2,106 | $1,745 | 82.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 123 | 152 | $18,392 | $1,704 | 9.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 13 | 13 | $3,198 | $1,357 | 42.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 22 | $1,650 | $1,235 | 74.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 24 | 26 | $4,732 | $1,117 | 23.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $1,050 | $1,007 | 95.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 22 | 24 | $1,200 | $911.40 | 76.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 33 | 34 | $4,114 | $841.80 | 20.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 66 | $2,574 | $711.26 | 27.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 15 | $1,485 | $612.43 | 41.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $702.00 | $581.76 | 82.9% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2023 | 24 | 26 | $702.00 | $349.96 | 49.9% |
About Dr. Santiago Candocia, M.D
Dr. Santiago Candocia, M.D is a Internal Medicine healthcare provider based in Winnetka, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780764019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Santiago Candocia, M.D has received a total of $161.59 in payments from pharmaceutical and medical device companies, with $39.86 received in 2024. These payments were reported across 4 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($161.59).
As a Medicare-enrolled provider, Candocia has provided services to 4,334 Medicare beneficiaries, totaling 7,016 services with total Medicare billing of $396,171. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Winnetka, IL
- Active Since 10/17/2006
- Last Updated 02/15/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1780764019
Products in Payments
- Ozempic (Drug) $76.38
- SAPIEN 3 Ultra RESILIA (Device) $39.86
- SYNTHROID (Drug) $23.79
- SPIRIVA RESPIMAT (Drug) $21.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Winnetka
Dr. Kristi Tough Desapri, M.d, M.D
Internal Medicine — Payments: $328,189
Dr. Alfred Torrence, Md, MD
Internal Medicine — Payments: $3,090
Claire Kenneally, M.d, M.D
Internal Medicine — Payments: $3,024
David Donnersberger, Md, MD
Internal Medicine — Payments: $2,336
Dr. Robin Wind, M.d, M.D
Internal Medicine — Payments: $2,236
Roman Mandzij, Do, DO
Internal Medicine — Payments: $1,991